Clinical Trial Update: LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 open-label study of LEO 32731 in healthy subjects has completed, featuring a four-way crossover and a food-effect assessment to characterize pharmacokin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• LEO 32731

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED